| Klotho converts canonical FGF receptor into a specific receptor for FGF23 I Urakawa, Y Yamazaki, T Shimada, K Iijima, H Hasegawa, K Okawa, ... Nature 444 (7120), 770-774, 2006 | 2178 | 2006 |
| FGF‐23 is a potent regulator of vitamin D metabolism and phosphate homeostasis T Shimada, H Hasegawa, Y Yamazaki, T Muto, R Hino, Y Takeuchi, ... Journal of bone and mineral research 19 (3), 429-435, 2004 | 2165 | 2004 |
| Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism T Shimada, M Kakitani, Y Yamazaki, H Hasegawa, Y Takeuchi, T Fujita, ... The Journal of clinical investigation 113 (4), 561-568, 2004 | 1830 | 2004 |
| Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia T Shimada, S Mizutani, T Muto, T Yoneya, R Hino, S Takeda, Y Takeuchi, ... Proceedings of the National Academy of Sciences 98 (11), 6500-6505, 2001 | 1667 | 2001 |
| Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia Y Yamazaki, R Okazaki, M Shibata, Y Hasegawa, K Satoh, T Tajima, ... The Journal of Clinical Endocrinology & Metabolism 87 (11), 4957-4960, 2002 | 727 | 2002 |
| FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa T Shimada, I Urakawa, Y Yamazaki, H Hasegawa, R Hino, T Yoneya, ... Biochemical and biophysical research communications 314 (2), 409-414, 2004 | 533 | 2004 |
| Mutant FGF-23 Responsible for Autosomal Dominant Hypophosphatemic Rickets Is Resistant to Proteolytic Cleavage and Causes Hypophosphatemia in Vivo T Shimada, T Muto, I Urakawa, T Yoneya, Y Yamazaki, K Okawa, ... Endocrinology 143 (8), 3179-3182, 2002 | 513 | 2002 |
| Association between activating mutations of calcium-sensing receptor and Bartter's syndrome S Watanabe, S Fukumoto, H Chang, Y Takeuchi, Y Hasegawa, R Okazaki, ... The Lancet 360 (9334), 692-694, 2002 | 447 | 2002 |
| Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism T Shimada, Y Yamazaki, M Takahashi, H Hasegawa, I Urakawa, ... American Journal of Physiology-Renal Physiology 289 (5), F1088-F1095, 2005 | 433 | 2005 |
| Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease H Hasegawa, N Nagano, I Urakawa, Y Yamazaki, K Iijima, T Fujita, ... Kidney international 78 (10), 975-980, 2010 | 425 | 2010 |
| Bone as an endocrine organ S Fukumoto, TJ Martin Trends in Endocrinology & Metabolism 20 (5), 230-236, 2009 | 423 | 2009 |
| Ghrelin directly regulates bone formation N Fukushima, R Hanada, H Teranishi, Y Fukue, T Tachibana, H Ishikawa, ... Journal of Bone and Mineral Research 20 (5), 790-798, 2005 | 409 | 2005 |
| Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder M Fukagawa, K Yokoyama, F Koiwa, M Taniguchi, T Shoji, JJ Kazama, ... Therapeutic Apheresis and Dialysis 17 (3), 247-288, 2013 | 404 | 2013 |
| Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency T Shigematsu, JJ Kazama, T Yamashita, S Fukumoto, T Hosoya, F Gejyo, ... American Journal of Kidney Diseases 44 (2), 250-256, 2004 | 388 | 2004 |
| Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways Y Shinoda, M Yamaguchi, N Ogata, T Akune, N Kubota, T Yamauchi, ... Journal of cellular biochemistry 99 (1), 196-208, 2006 | 383 | 2006 |
| A microRNA regulatory mechanism of osteoblast differentiation H Inose, H Ochi, A Kimura, K Fujita, R Xu, S Sato, M Iwasaki, S Sunamura, ... Proceedings of the National Academy of Sciences 106 (49), 20794-20799, 2009 | 353 | 2009 |
| Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients S Nakanishi, JJ Kazama, T Nii-Kono, K Omori, T Yamashita, S Fukumoto, ... Kidney international 67 (3), 1171-1178, 2005 | 294 | 2005 |
| Therapeutic effects of anti‐FGF23 antibodies in hypophosphatemic rickets/osteomalacia Y Aono, Y Yamazaki, J Yasutake, T Kawata, H Hasegawa, I Urakawa, ... Journal of Bone and Mineral Research 24 (11), 1879-1888, 2009 | 284 | 2009 |
| Anti‐FGF23 neutralizing antibodies show the physiological role and structural features of FGF23 Y Yamazaki, T Tamada, N Kasai, I Urakawa, Y Aono, H Hasegawa, ... Journal of Bone and Mineral Research 23 (9), 1509-1518, 2008 | 241 | 2008 |
| Stimulation of osteoclast formation by 1, 25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice S Takeda, T Yoshizawa, Y Nagai, H Yamato, S Fukumoto, K Sekline, ... Endocrinology 140 (2), 1005-1008, 1999 | 233 | 1999 |
Yasuhiro TakeuchiDirector of Endocrine Center, Toranomon HospitalVerified email at umin.ac.jp
